Hero Fincorp LimitedUnlisted Shares
₹ 975▼18.41%(220.00)
About the company
Hero FinCorp Limited (HFCL) was incorporated in 1991 as Hero Honda FinLease Limited and was later renamed following the restructuring of its parent company, Hero MotoCorp Limited (formerly Hero Honda Motors Limited).
HFCL is a leading NBFC offering a wide range of financial products, including vehicle loans, personal loans, loans against property, SME financing, leasing, bill discounting, and other financial services. It also operates Hero Housing Finance Limited, its wholly owned subsidiary, which provides home loan solutions.
As of 2020, Hero FinCorp had a strong pan-India presence with 938 dealerships, 4,000+ customer touchpoints, and operations across 1,900+ cities, towns, and villages. Its non-retail business, including Loan Against Property, SME, and Emerging Corporate Finance, operates from 50 locations, processing over 800 applications every month.
Fundamentals
Valuation
- 52 week high
- ₹1495
- 52 week low
- ₹975
- P/B ratio
- 2.14
- ROE (%)
- -3.82%
- Book value
- ₹456.66
- Face value
- ₹10
- Valuation
- —
Registry
- PAN number
- AAACH0157J
- ISIN number
- INE957N01016
- CIN
- U74899DL1991PLC046774
Figures in cr ·
Financials
| P&L Statement | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| PAT | 479 | 637 | 110 | -226 |
| EPS | 37.62 | 50.16 | 8.63 | -17.43 |
| Interest earned | 5719 | 7479 | 8589 | 8255.5 |
| Interest expended | 2173 | 3097 | 3827 | 3766 |
| Other income | 728 | 880 | 1314 | 1337.5 |
| Operating expenses | 2288 | 2513 | 2935 | 3380 |
| Gross NPA (%) | 5.37 | 4.02 | 5.05 | 3.99 |
| Net NPA (%) | 2.79 | 2 | 2.3 | 1.76 |
Shareholding Pattern
Leadership
| Name | Role | Experience | |
|---|---|---|---|
| Pawan Munjal | Chairman | 40+ yrs experience | — |
| Abhimanyu Munjal | Joint MD & CEO | 20+ yrs experience | |
| Renu Munjal | MD | 30+ yrs experience | — |
Frequently asked questions
Common questions on Hero Fincorp Limited Unlisted Shares—tap a row to read the answer.
Q.1Can I buy Hero FinCorp unlisted shares in India?
Yes, Hero FinCorp unlisted shares can be purchased through registered intermediaries dealing in unlisted securities. Investors must complete the required KYC formalities and hold a valid Demat account before purchasing.
Q.2Does Hero FinCorp have IPO plans?
Hero FinCorp has taken steps toward a public listing by filing IPO-related documents with the market regulator. Investors should refer to official announcements for the latest IPO updates.
Q.3What documents are required to buy Hero FinCorp unlisted shares?
To purchase unlisted shares, investors generally need:
PAN Card
Aadhaar Card
Client Master Report (CMR)
Active Demat Account
Bank account details for fund transfer
Q.4Is there a lock-in period for Hero FinCorp unlisted shares after the IPO?
For most retail investors purchasing pre-IPO shares, SEBI regulations generally require a 6-month lock-in period from the date of listing. Investors should verify the applicable rules before investing.
Q.5Why buy Hero FinCorp unlisted shares through Dhankirti?
Dhankirti provides a transparent platform for buying and selling unlisted shares, offering competitive pricing, secure transactions, timely execution, and dedicated customer support throughout the investment process.
Trending shares
High-demand unlisted opportunities currently available for trade.
From the blog
Notes on unlisted markets, execution hygiene, and how we think about risk—no hype, no ticker spam.

APTUS PHARMA IPO
Aptus Pharma Limited rolled out its 100% book-built BSE SME public offering worth ₹13.02 Crore. Review crucial parameters for retail investors, featuring the ₹65–₹70 price band, working capital allocations, and an evaluation of its contract-manufacturing partner model.

NEPHROPLUS (NEPHROCARE HEALTH SERVICES) IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

APOLLO TECHNO INDUSTRIES IPO
Apollo Techno Industries Limited has announced its public offering details. Explore the essential investment parameters for retail and institutional bidders, highlighting the fixed price band, lot structure, key market deadlines, and an overview of its industrial manufacturing footprint.

NEOCHEM BIO IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

ANONDITA MEDICARE IPO
Anondita Medicare Limited rolled out its 100% book-built SME public offering worth ₹69.50 Crore on the NSE SME platform. Dig into the critical parameters for investors, highlighting the ₹137–₹145 price band, key working capital objectives, and an analysis of its flagship brand 'COBRA' within the growing sexual wellness market.

NEPTUNE LOGITEK IPO
Explore the Neptune Logitek IPO, including issue details, business strengths, risks, and investment analysis.
